Related Experiment Videos
Patient safety: rejecting the status quo
1Center for Medical Consumers, USA. medconsumers@earthlink.net
North Carolina Medical Journal
|June 15, 2005
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Development of a DUX4-targeting antibody oligonucleotide conjugate as a therapy for FSHD.
Nucleic acids research·2026
Delpacibart etedesiran improves the molecular pathology of myotonic dystrophy type 1 in the phase 1/2 MARINA study.
Molecular therapy : the journal of the American Society of Gene Therapy·2026
An Antibody-Oligonucleotide Conjugate for Myotonic Dystrophy Type 1.
The New England journal of medicine·2026
Assessing Hybridization-Dependent Off-Target Risk for Therapeutic Oligonucleotides: Updated Industry Recommendations.
Nucleic acid therapeutics·2025
Targeted tissue delivery of RNA therapeutics using antibody-oligonucleotide conjugates (AOCs).
Nucleic acids research·2023
Trends in Non-Emergency Medical Transportation During Medicaid Transformation in North Carolina.
North Carolina medical journal·2026
Prevalence and Risk Factors for Suicidal Ideation and Attempts Among Black LGBTQ+ Young Adults.
North Carolina medical journal·2026
Pregnancy Medicaid in North Carolina: An Interview with Maternal and Child Health Professional Jessica Beach.
North Carolina medical journal·2026
Building a Gateway for Prison Re-Entry: An Interview with Change Agent Philip Cooper.
North Carolina medical journal·2026
Free Clinics in the United States: Challenges, Models, and a Sustainable Alternative Approach.
North Carolina medical journal·2026
Comparing the Feasibility of S-Patch vs 24-Hour Holter in Frail Older People With Falls: Randomized Open-Label Crossover Pilot Study.
JMIR rehabilitation and assistive technologies·2026
Finite-State Fuzzy Constrained Markov Decision Processes for Individualized Decision Making.
IEEE transactions on cybernetics·2026